4basebio PLC
XETRA: 88Q.DE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Deutsche Börse
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Amy Jo Walker
- Employees
- 101
- Headquarters
- Cambridge, United Kingdom
- IPO year
- 2021
- Market cap
- €81.3M
- Website
- http://www.4basebio.com
Loading 88Q…
Loading profile data…Frequently asked questions about 88Q
What does 4basebio PLC (88Q.DE) do?
4basebio Plc is a biotechnology company, which engages in the business of developing advanced therapy medicinal products through synthetic DNA products and non-viral, cell targeting nucleic acid delivery platforms. The firm is involved in manufacturing and supplying high quality synthetic DNA products for research, therapeutic, and pharmacologic...
Where does 88Q.DE trade?
4basebio PLC (88Q.DE) trades on the Deutsche Börse.
What sector is 88Q.DE in?
4basebio PLC (88Q.DE) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of 4basebio PLC?
Amy Jo Walker is the chief executive officer of 4basebio PLC (88Q.DE).
Where is 4basebio PLC headquartered?
4basebio PLC is headquartered in United Kingdom.
Does 88Q.DE pay a dividend?
4basebio PLC (88Q.DE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 88Q.DE go public?
4basebio PLC (88Q.DE) completed its initial public offering in 2021.